London, UK (PRWEB) September 28, 2015
The markets for clinical chemistry and immunodiagnostics are undergoing dramatic transformation driven by convergence of novel and tougher regulations; advancements in systems engineering, diagnostic technologies, automation, and IT; as well as the ever-growing degree of intensity of rivalry among competitors in the marketplace. A number of segments, such as routine chemistry, are currently bearing a resemblance to commodity markets, where cost per test and product positioning are more vital than underlying technology. This developing marketplace is offering a host of bright opportunities for a variety of novel instruments, reagent systems, and auxiliary products including devices for preparing specimens, calibrators, and controls.
Sysmex, Abbott, IL, Alere, Tosoh, Beckman Coulter/Danaher, Biomedical Diagnostics, Siemens, bioMerieux, Eiken, Fujirebio/Innogenetics, DiaSorin, Ortho-Clinical Diagnotics, Kyowa Medex, Roche, and Wako, amongst others, are the dominant players in the market.
New research report “2015 Global Immunodiagnostic Markets: Clinical Chemistry, Drugs of Abuse, Endocrine Function, Immunoproteins, Special Chemistry, Therapeutic Drug Monitoring (TDM), Tumor Markers - Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts for 100 Tests” created by VPGMarketResearch.com has been recently added at MarketPublishers.com.
Title: 2015 Global Immunodiagnostic Markets: Clinical Chemistry, Drugs of Abuse, Endocrine Function, Immunoproteins, Special Chemistry, Therapeutic Drug Monitoring (TDM), Tumor Markers - Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts for 100 Tests
Published: September, 2015
Price: US$ 37,500.00
The study is a unique source of information on the global immunodiagnostic marketplace. It presents an all-round overview of the global market, estimates the facilities carrying out clinical chemistry and immunodiagnostic tests across the reviewed countries, and also sales and test volume projections by country. The report canvasses the market dynamics, structure, trends, size, growth, and top suppliers, by country; test volume and sales projections for more than 100 clinical chemistry, cancer, TDM, immunoprotein, endocrine and abused drug assays, by market segment and country. The research publication presents an assessment of the respective tests, and a review of present-day instrumentation technologies, and feature comparisons of high-, medium-, and low-volume/point-of-care (POC) analyzers. The report also provides an analysis of the technologies and their potential market applications alongside a listing of companies elaborating or marketing novel technologies and products by test; provides a discussion of the leading suppliers and emerging entrants into the market.
- 360-degree overview of the market globally;
- in-depth investigation of market trends prevailing in leading markets;
- detailed market segmentation analysis;
- insights into present-day and emerging assays;
- coverage of technologies alongside their potential applications;
- competitive analysis;
- strategic recommendations;
- and more.
More new reports by the publisher can be found at VPGMarketResearch.com page.